RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-4656
Malaria parasiteP. berghei
Genotype
Genetic modification not successful
MutatedGene model (rodent): PBANKA_0926700; Gene model (P.falciparum): PF3D7_1121600; Gene product: exported protein 1 (HEP17, EXP1)
Details mutation: N-terminal(NT)-domain truncation of PbEXP1
Transgene
Transgene not Plasmodium: GFP (gfp-mu3)
Promoter: Gene model: PBANKA_1133300; Gene model (P.falciparum): PF3D7_1357100; Gene product: elongation factor 1-alpha (eef1a)
3'UTR: Gene model: PBANKA_0719300; Gene product: bifunctional dihydrofolate reductase-thymidylate synthase, putative (dhfr/ts)
Replacement locus: Gene model: PBANKA_0306000; Gene product: 6-cysteine protein (230p)
PhenotypeNo phenotype has been described
Last modified: 7 August 2019, 17:20
  *RMgm-4656
Successful modificationThe gene/parasite could not be changed/generated by the genetic modification.
The following genetic modifications were attempted Gene mutation, Introduction of a transgene
Number of attempts to introduce the genetic modification Unknown
Reference (PubMed-PMID number) Reference 1 (PMID number) : 31364224
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone P. berghei ANKA 507cl1 (RMgm-7)
Other information parent lineP.berghei ANKA 507cl1 (RMgm-7) is a reference ANKA mutant line which expresses GFP under control of a constitutive promoter. This reference line does not contain a drug-selectable marker (PubMed: PMID: 16242190).
Attempts to generate the mutant parasite were performed by
Name PI/ResearcherWolanin K, Mueller AK, Prudencio M
Name Group/DepartmentInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina
Name InstituteUniversidade de Lisboa
CityLisbon
CountryPortugal

  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_0926700
Gene Model P. falciparum ortholog PF3D7_1121600
Gene productexported protein 1
Gene product: Alternative nameHEP17, EXP1
Details of the genetic modification
Short description of the mutationN-terminal(NT)-domain truncation of PbEXP1
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Click to view information
Click to hide information
The unsuccessful attempts to truncate the N-terminal portion of EXP1 indicate an essential function of this region during asexual blood stage growth.

Exp1 (HEP17) is a protein that localizes to the parasitophorous vacuole membrane (PVM) of blood stages and liver stages
Pb/PfEXP1’s topology includes an N-terminal (NT) domain (aa 1-75/1-79) that harbors a classical signal peptide (aa 1-23); a putative catalytic domain that includes the Pf Arg70 residue and is presumed to be responsible for GST activity in blood stage parasites; an internal hydrophobic region typical of transmembrane anchor sequences (aa 75-97/79-101); and a C-terminal (CT) domain (aa 97-166/101-162) that includes a C1 (aa 103-136/107-134) and a C2 (aa 137-166/135-162) region, as defined in (Sa et al., 2017). In both blood and liver parasite stages, EXP1 is proposed to be integrated into the PVM with the N-terminus facing the lumen of the PV, and the C-terminus exposed to the host cell cytosol.

In order to dissect the functional role of different domains of PbEXP1, we attempted to generate modified versions of this protein bearing a truncated version of its N- and C-terminal domains. Despite multiple attempts, we were unable to generate a modified version of PbEXP1 lacking the NT domain (PbEXP1ΔNT; RMgm-4656), suggesting that it is essential for blood stage development of Pb parasites. However, transgenic Pb parasite lines expressing a CT domain-truncated version of PbEXP1 were successfully generated in both the PbANKA (PbWT) and PbGFPcon (PbGFP) parental parasite lines, yielding their PbEXP1ΔCT and PbGFPEXP1ΔCT mutated counterparts, respectively, and showing that Pb blood stages can develop in the absence of the PbEXP1 CT domain. Successful deletion of the CT domain in the PbEXP1ΔCT parasites was confirmed by Western blot using two different anti-EXP1 antibodies that bind either to epitopes present on the full length PbEXP1 protein or to epitopes present only on the protein’s C-terminus.
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationTo generate the PbGFPEXP1ΔCT parasite lines, a 3’ UTR fragment was amplified by using 3’UTR PbEXP1for and 3’UTR PbEXP1rev primers, and a 5’ fragment including the ORF without the last 207 bp of PbEXP1 was amplified with 5’UTR PbEXP1 ORF dC2for (Sa et al., 2017) and 5’UTR PbEXP1 ORF dCTrev primers from PbWT genomic DNA (gDNA) and cloned into the b3D+ vector (Silvie, Goetz, & Matuschewski, 2008).
A similar strategy was used to generate the PbEXP1ΔNT parasite line. Briefly, a 5′ fragment without the last 114 bp coding N-terminal domain of EXP1 protein after signal peptide was amplified using primers 5’UTR SP PbEXP1for and 5’UTR SP PbEXP1rev together with full transmembrane domain (TM) containing C-terminal domain (CT) using primers TM CT PbEXP1for and TM CT PbEXP1rev from PbWT gDNA and cloned into the b3D+ vector containing the 3′ UTR fragment as described above. Before transfection, the targeting vectors were linearized by using restriction enzymes KpnI and NotI.

The unsuccessful attempts to truncate the N-terminal portion of EXP1 indicate an essential function of this region during asexual blood stage growth.

Exp1 (HEP17) is a protein that localizes to the parasitophorous vacuole membrane (PVM) of blood stages and liver stages
Pb/PfEXP1’s topology includes an N-terminal (NT) domain (aa 1-75/1-79) that harbors a classical signal peptide (aa 1-23); a putative catalytic domain that includes the Pf Arg70 residue and is presumed to be responsible for GST activity in blood stage parasites; an internal hydrophobic region typical of transmembrane anchor sequences (aa 75-97/79-101); and a C-terminal (CT) domain (aa 97-166/101-162) that includes a C1 (aa 103-136/107-134) and a C2 (aa 137-166/135-162) region, as defined in (Sa et al., 2017). In both blood and liver parasite stages, EXP1 is proposed to be integrated into the PVM with the N-terminus facing the lumen of the PV, and the C-terminus exposed to the host cell cytosol.

In order to dissect the functional role of different domains of PbEXP1, we attempted to generate modified versions of this protein bearing a truncated version of its N- and C-terminal domains. Despite multiple attempts, we were unable to generate a modified version of PbEXP1 lacking the NT domain (PbEXP1ΔNT; RMgm-4656), suggesting that it is essential for blood stage development of Pb parasites. However, transgenic Pb parasite lines expressing a CT domain-truncated version of PbEXP1 were successfully generated in both the PbANKA (PbWT) and PbGFPcon (PbGFP) parental parasite lines, yielding their PbEXP1ΔCT and PbGFPEXP1ΔCT mutated counterparts, respectively, and showing that Pb blood stages can develop in the absence of the PbEXP1 CT domain. Successful deletion of the CT domain in the PbEXP1ΔCT parasites was confirmed by Western blot using two different anti-EXP1 antibodies that bind either to epitopes present on the full length PbEXP1 protein or to epitopes present only on the protein’s C-terminus.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP (gfp-mu3)
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitegfp (FACS)
Promoter of the selectable markereef1a
Selection (positive) procedureFACS (flowsorting)
Selection (negative) procedureNo
Additional remarks genetic modification
Additional remarks selection procedureThis reporter mutant expressing GFP does not contain a drug-selectable marker. This mutant has been selected by FACS sorting after transfection based on GFP fluorescence.
Other details transgene
Promoter
Gene Model of Parasite PBANKA_1133300
Gene Model P. falciparum ortholog PF3D7_1357100
Gene productelongation factor 1-alpha
Gene product: Alternative nameeef1a
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite PBANKA_0719300
Gene productbifunctional dihydrofolate reductase-thymidylate synthase, putative
Gene product: Alternative namedhfr/ts
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionReplacement locus
Gene Model of Parasite PBANKA_0306000
Gene product6-cysteine protein
Gene product: Alternative name230p
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4